Firas Abdollah, MD
Urology · Detroit, MINPI 1932591898
Payments from drug & device makers
What this record shows
This record is dominated by education: $13,750 of the $20,187 with a category attached, or 68.1%. Intuitive Surgical accounts for 94.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $11,463, more than ten times the $514 reported in 2022.
Across 34 payments — averaging $593.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$19K
- Koelis Inc.$763
- Ferring Pharmaceuticals Inc.$130
- Endo Pharmaceuticals Inc.$122
- Ambu Inc.$104
- Procept Biorobotics Corporation$90
Across 1 payment — averaging $4750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dendreon Pharmaceuticals LLC$5K
What the payments were for
- Consulting fees$4502%
- Travel & lodging$3,63118%
- Food & beverage$2,35612%
- Education$13,75068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 25 | $18,977 |
| Koelis Inc. | 3 | $763 |
| Ferring Pharmaceuticals Inc. | 2 | $130 |
| Endo Pharmaceuticals Inc. | 1 | $122 |
| Ambu Inc. | 2 | $104 |
| Procept Biorobotics Corporation | 1 | $90 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$15,842
- DA VINCI SP$3,000
- TRINITY$763
- XIAFLEX$122
- ADSTILADRIN$104
How this compares
$20,187 in reported general payments places this provider in the 85th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 186 | $3,317 |
| Finasteride | 86 | $1,417 |
| Trospium Chloride | 16 | $820 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other urology in Detroit
- Aram LoebDetroit$112K
- David LeavittDetroit$59K
- Craig RogersDetroit$25K
- Naveen KachrooDetroit$25K
- Amit PatelDetroit$22K
- Asha JamzadehDetroit$21K
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
- William JohnstonLivonia$675K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.